Radioligands for Imaging Dopamine and Serotonin Receptors and Transporters.
- Author:
Dae Yoon CHI
- Publication Type:Original Article
- Keywords:
Dopamine;
Serotonin;
Receptor;
Transporter;
Radioligand;
Radiopharmaceuticals
- MeSH:
Dopamine*;
Humans;
Ligands;
Photons;
Radioisotopes;
Radiopharmaceuticals;
Receptors, Serotonin*;
Serotonin*;
Tomography, Emission-Computed, Single-Photon
- From:Korean Journal of Nuclear Medicine
2000;34(3):159-168
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
In the 1980s, techniques to image the human subjects in a rhree-dimensiona1 direction were developed, Two major techniques are SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) which allow the detector to detect a single photon or annihilation photons emitted from the subjects injected with radiopharmaceuticals. Since the latter two techniques can measure the density of receptors, enzymes and transporters in living human, it may be very important project to develop selective methods of labeling with radionuclides and to develop new radiopharmaceuticals. There has been a considerable interest in developing new compounds which specifically bind to dopamine and serotonin receptor and transporters, and it will be thus very useful to label those compounds with radionuclides in order to gain a better understanding in biochemical and pharmacological interactions in living human. This review rnentions the characteristics of radioligands for the imaging of dopamine and serotonin receptors and transporters. Although significant progress has been achieved in the development of new PET and SPECT ligands for in vivo imaging of those receptors and transporters, there are continuous needs of new diagnostic radioligands,
